These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 19265162)

  • 1. C3a and C5a are chemotactic factors for human mesenchymal stem cells, which cause prolonged ERK1/2 phosphorylation.
    Schraufstatter IU; Discipio RG; Zhao M; Khaldoyanidi SK
    J Immunol; 2009 Mar; 182(6):3827-36. PubMed ID: 19265162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C5a differentially stimulates the ERK1/2 and p38 MAPK phosphorylation through independent signaling pathways to induced chemotactic migration in RAW264.7 macrophages.
    Chiou WF; Tsai HR; Yang LM; Tsai WJ
    Int Immunopharmacol; 2004 Oct; 4(10-11):1329-41. PubMed ID: 15313431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lovastatin protects mesenchymal stem cells against hypoxia- and serum deprivation-induced apoptosis by activation of PI3K/Akt and ERK1/2.
    Xu R; Chen J; Cong X; Hu S; Chen X
    J Cell Biochem; 2008 Jan; 103(1):256-69. PubMed ID: 17497701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway.
    Nilsson G; Johnell M; Hammer CH; Tiffany HL; Nilsson K; Metcalfe DD; Siegbahn A; Murphy PM
    J Immunol; 1996 Aug; 157(4):1693-8. PubMed ID: 8759757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of C3a activity: internalization of the human C3a receptor and its inhibition by C5a.
    Settmacher B; Bock D; Saad H; Gärtner S; Rheinheimer C; Köhl J; Bautsch W; Klos A
    J Immunol; 1999 Jun; 162(12):7409-16. PubMed ID: 10358194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-1 upregulates anaphylatoxin receptors on mononuclear cells.
    Takabayashi T; Shimizu S; Clark BD; Beinborn M; Burke JF; Gelfand JA
    Surgery; 2004 May; 135(5):544-54. PubMed ID: 15118592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells.
    Monsinjon T; Gasque P; Chan P; Ischenko A; Brady JJ; Fontaine MC
    FASEB J; 2003 Jun; 17(9):1003-14. PubMed ID: 12773483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of receptors for complement anaphylatoxins C3a and C5a following permanent focal cerebral ischemia in the mouse.
    Van Beek J; Bernaudin M; Petit E; Gasque P; Nouvelot A; MacKenzie ET; Fontaine M
    Exp Neurol; 2000 Jan; 161(1):373-82. PubMed ID: 10683302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential activation of ERK1,2 MAP kinase signaling pathway in mesenchymal stem cell from control and osteoporotic postmenopausal women.
    Rodríguez JP; Ríos S; Fernández M; Santibañez JF
    J Cell Biochem; 2004 Jul; 92(4):745-54. PubMed ID: 15211572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agonist-dependent phosphorylation of N-formylpeptide and activation peptide from the fifth component of C (C5a) chemoattractant receptors in differentiated HL60 cells.
    Tardif M; Mery L; Brouchon L; Boulay F
    J Immunol; 1993 Apr; 150(8 Pt 1):3534-45. PubMed ID: 8468487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regulation of the C3a and C5a receptors (CD88) by IFN-gamma and PMA in U937 cells and related myeloblastic cell lines.
    Burg M; Martin U; Bock D; Rheinheimer C; Köhl J; Bautsch W; Klos A
    J Immunol; 1996 Dec; 157(12):5574-81. PubMed ID: 8955209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of C3a, C5a and their receptor antagonists on the expression of beta-catenin in renal tubular cells].
    Liu F; Gou R; Huang J; Fu P
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jan; 42(1):74-7. PubMed ID: 21355306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of cytokines by human astrocytomas following stimulation by C3a and C5a anaphylatoxins: specific increase in interleukin-6 mRNA expression.
    Sayah S; Ischenko AM; Zhakhov A; Bonnard AS; Fontaine M
    J Neurochem; 1999 Jun; 72(6):2426-36. PubMed ID: 10349852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement factors C3a and C5a have distinct hemodynamic effects in the rat.
    Proctor LM; Moore TA; Monk PN; Sanderson SD; Taylor SM; Woodruff TM
    Int Immunopharmacol; 2009 Jun; 9(6):800-6. PubMed ID: 19285573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C5a as a model for chemotactic factor-stimulated tyrosine phosphorylation in the human neutrophil.
    Richard S; Farrell CA; Shaw AS; Showell HJ; Connelly PA
    J Immunol; 1994 Mar; 152(5):2479-87. PubMed ID: 8133059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of high- and low-affinity receptors for C3a on the human mast cell line, HMC-1.
    Legler DF; Loetscher M; Jones SA; Dahinden CA; Arock M; Moser B
    Eur J Immunol; 1996 Apr; 26(4):753-8. PubMed ID: 8625964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning and characterization of rat C3a receptor: differential expression of rat C3a and C5a receptors by LPS stimulation.
    Fukuoka Y; Ember JA; Hugli TE
    Biochem Biophys Res Commun; 1998 Jan; 242(3):663-8. PubMed ID: 9464274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C5a, but not C3a, increases VEGF secretion in ARPE-19 human retinal pigment epithelial cells.
    Cortright DN; Meade R; Waters SM; Chenard BL; Krause JE
    Curr Eye Res; 2009 Jan; 34(1):57-61. PubMed ID: 19172471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signaling through C5aR is not involved in basal neurogenesis.
    Bogestål YR; Barnum SR; Smith PL; Mattisson V; Pekny M; Pekna M
    J Neurosci Res; 2007 Oct; 85(13):2892-7. PubMed ID: 17551982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement c3a and c5a induce different signal transduction cascades in endothelial cells.
    Schraufstatter IU; Trieu K; Sikora L; Sriramarao P; DiScipio R
    J Immunol; 2002 Aug; 169(4):2102-10. PubMed ID: 12165538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.